Gene Network Analysis of Hepatocellular Carcinoma Identifies Modules Associated with Disease Progression, Survival, and Chemo Drug Resistance

References

• Silverman EK, Schmidt HH, Anastasiadou E, et al. Molecular networks in network medicine: development and applications. Wires Syst Biol Med. 2020;12(6):e1489. doi:10.1002/wsbm.1489
   Google Scholar
• Paci P, Fiscon G, Conte F, Wang R-S, Farina L, Loscalzo J. Gene co-expression in the interactome: moving from correlation toward causation via an integrated approach to disease module discovery. Npj Syst Biol Appl. 2021;7(1):3. doi:10.1038/s41540-020-00168-0
   PubMed Web of Science ®Google Scholar
• Fiscon G, Paci P. SAveRUNNER: an R-based tool for drug repurposing. BMC Bioinform. 2021;22(1):150. doi:10.1186/s12859-021-04076-w
   PubMed Web of Science ®Google Scholar
• Lamb J, Crawford ED, Peck D, et al. The Connectivity Map: using gene-expression signatures to connect small molecules, genes, and disease. Science. 2006;313(5795):1929–1935. doi:10.1126/science.1132939
   PubMed Web of Science ®Google Scholar
• Langfelder P, Horvath S. WGCNA: an R package for weighted correlation network analysis. BMC Bioinform. 2008;9(1):559. doi:10.1186/1471-2105-9-559
   PubMed Web of Science ®Google Scholar
• D’Haeseleer P, Liang S, Somogyi R. Genetic network inference: from co-expression clustering to reverse engineering. Bioinformatics. 2000;16(8):707–726. doi:10.1093/bioinformatics/16.8.707
   PubMed Web of Science ®Google Scholar
• Lai X, Lin P, Ye J, Liu W, Lin S, Lin Z. Reference module-based analysis of ovarian cancer transcriptome identifies important modules and potential drugs. Biochem Genet. 2021. doi:10.1007/s10528-021-10101-7
   Web of Science ®Google Scholar
• Finn RS, Aleshin A, Dering J, et al. Molecular subtype and response to dasatinib, an Src/Abl small molecule kinase inhibitor, in hepatocellular carcinoma cell lines in vitro. Hepatology. 2013;57(5):1838–1846. doi:10.1002/hep.26223
   PubMed Web of Science ®Google Scholar
• Caruso S, Calatayud AL, Pilet J, et al. Analysis of liver cancer cell lines identifies agents with likely efficacy against hepatocellular carcinoma and markers of response. Gastroenterology. 2019;157(3):760–776. doi:10.1053/j.gastro.2019.05.001
   PubMed Web of Science ®Google Scholar
• Qiu Z, Zou K, Zhuang L, et al. Hepatocellular carcinoma cell lines retain the genomic and transcriptomic landscapes of primary human cancers. Sci Rep. 2016;6:27411. doi:10.1038/srep27411
   PubMed Web of Science ®Google Scholar
• Qiu Z, Li H, Zhang Z, et al. A pharmacogenomic landscape in human liver cancers. Cancer Cell. 2019;36(2):179–193 e111. doi:10.1016/j.ccell.2019.07.001
   PubMed Web of Science ®Google Scholar
• Ghandi M, Huang FW, Jane-Valbuena J, et al. Next-generation characterization of the cancer cell line encyclopedia. Nature. 2019;569(7757):503–508. doi:10.1038/s41586-019-1186-3
   PubMed Web of Science ®Google Scholar
• Mas VR, Maluf DG, Archer KJ, et al. Genes involved in viral carcinogenesis and tumor initiation in hepatitis C virus-induced hepatocellular carcinoma. Mol Med. 2009;15(3–4):85–94. doi:10.2119/molmed.2008.00110
   PubMed Web of Science ®Google Scholar
• Chiyonobu N, Shimada S, Akiyama Y, et al. Fatty acid binding protein 4 (FABP4) overexpression in intratumoral hepatic stellate cells within hepatocellular carcinoma with metabolic risk factors. Am J Pathol. 2018;188(5):1213–1224. doi:10.1016/j.ajpath.2018.01.012
   PubMed Web of Science ®Google Scholar
• Diaz G, Engle RE, Tice A, et al. Molecular signature and mechanisms of Hepatitis D virus-associated hepatocellular carcinoma. Mol Cancer Res. 2018;16(9):1406–1419. doi:10.1158/1541-7786.MCR-18-0012
   PubMed Web of Science ®Google Scholar
• Bairoch A. The cellosaurus, a cell-line knowledge resource. J Biomol Tech. 2018;29(2):25–38. doi:10.7171/jbt.18-2902-002
   PubMedGoogle Scholar
• R: a language and environment for statistical computing [computer program]. Vienna, Austria; 2016.
   Google Scholar
• Zhang B, Horvath S. A general framework for weighted gene co-expression network analysis. Stat Appl Genet Mol. 2005;4:Article17. doi:10.2202/1544-6115.1128
   PubMed Web of Science ®Google Scholar
• Oldham MC, Konopka G, Iwamoto K, et al. Functional organization of the transcriptome in human brain. Nat Neurosci. 2008;11(11):1271–1282. doi:10.1038/nn.2207
   PubMed Web of Science ®Google Scholar
• Paci P, Colombo T, Fiscon G, Gurtner A, Pavesi G, Farina L. SWIM: a computational tool to unveiling crucial nodes in complex biological networks. Sci Rep. 2017;7(1):44797. doi:10.1038/srep44797
   PubMed Web of Science ®Google Scholar
• Reimand J, Arak T, Adler P, et al. g:Profiler-a web server for functional interpretation of gene lists (2016 update). Nucleic Acids Res. 2016;44(W1):W83–89. doi:10.1093/nar/gkw199
   PubMed Web of Science ®Google Scholar
• Licursi V, Conte F, Fiscon G, Paci P. MIENTURNET: an interactive web tool for microRNA-target enrichment and network-based analysis. BMC Bioinform. 2019;20(1):545. doi:10.1186/s12859-019-3105-x
   PubMed Web of Science ®Google Scholar
• Langfelder P, Luo R, Oldham MC, Horvath S. Is my network module preserved and reproducible? PloS Comput Biol. 2011;7(1):e1001057. doi:10.1371/journal.pcbi.1001057
   PubMed Web of Science ®Google Scholar
• Lopez-Canovas JL, Del Rio-Moreno M, Garcia-Fernandez H, et al. Splicing factor SF3B1 is overexpressed and implicated in the aggressiveness and survival of hepatocellular carcinoma. Cancer Lett. 2021;496:72–83. doi:10.1016/j.canlet.2020.10.010
   PubMed Web of Science ®Google Scholar
• Yu H, Shen H, Zhang Y, et al. CAV1 promotes HCC cell progression and metastasis through Wnt/beta-catenin pathway. PLoS One. 2014;9(9):e106451. doi:10.1371/journal.pone.0106451
   PubMed Web of Science ®Google Scholar
• Lee JS, Chu IS, Heo J, et al. Classification and prediction of survival in hepatocellular carcinoma by gene expression profiling. Hepatology. 2004;40(3):667–676. doi:10.1002/hep.20375
   PubMed Web of Science ®Google Scholar
• Yu DC, Chen XY, Li X, et al. Transcript levels of spindle and kinetochore-associated complex 1/3 as prognostic biomarkers correlated with immune infiltrates in hepatocellular carcinoma. Sci Rep. 2021;11(1):11165. doi:10.1038/s41598-021-89628-z
   PubMed Web of Science ®Google Scholar
• Ponten F, Jirstrom K, Uhlen M. The human protein atlas – a tool for pathology. J Pathol. 2008;216(4):387–393. doi:10.1002/path.2440
   PubMed Web of Science ®Google Scholar
• Sze KM, Ho DW, Chiu YT, et al. Hepatitis B virus-telomerase reverse transcriptase promoter integration harnesses host ELF4, resulting in telomerase reverse transcriptase gene transcription in hepatocellular carcinoma. Hepatology. 2021;73(1):23–40. doi:10.1002/hep.31231
   PubMed Web of Science ®Google Scholar
• Kobayashi T, Nakazono K, Tokuda M, Mashima Y, Dynlacht BD, Itoh H. HDAC2 promotes loss of primary cilia in pancreatic ductal adenocarcinoma. EMBO Rep. 2017;18(2):334–343. doi:10.15252/embr.201541922
   PubMed Web of Science ®Google Scholar
• Copaja M, Venegas D, Aranguiz P, et al. Simvastatin disrupts cytoskeleton and decreases cardiac fibroblast adhesion, migration and viability. Toxicology. 2012;294(1):42–49. doi:10.1016/j.tox.2012.01.011
   PubMed Web of Science ®Google Scholar
• Zhou Q, Guo X, Choksi R. Activation of focal adhesion kinase and src mediates acquired sorafenib resistance in A549 human lung adenocarcinoma xenografts. J Pharmacol Exp Ther. 2017;363(3):428–443. doi:10.1124/jpet.117.240507
   PubMed Web of Science ®Google Scholar
• Iizuka K, Niwa H, Kato T, Takeda J. Dasatinib improves insulin sensitivity and affects lipid metabolism in a patient with chronic myeloid leukaemia. BMJ Case Rep. 2016;2016. doi:10.1136/bcr-2015-214284
   Google Scholar
• Chang AY, Wang M. Molecular mechanisms of action and potential biomarkers of growth inhibition of dasatinib (BMS-354825) on hepatocellular carcinoma cells. BMC Cancer. 2013;13:267. doi:10.1186/1471-2407-13-267
   PubMed Web of Science ®Google Scholar
• Masuda M, Chen WY, Miyanaga A, et al. Alternative mammalian target of rapamycin (mTOR) signal activation in sorafenib-resistant hepatocellular carcinoma cells revealed by array-based pathway profiling. Mol Cell Proteomics. 2014;13(6):1429–1438. doi:10.1074/mcp.M113.033845
   PubMed Web of Science ®Google Scholar
• Feng J, Dai W, Mao Y, et al. Simvastatin re-sensitizes hepatocellular carcinoma cells to sorafenib by inhibiting HIF-1alpha/PPAR-gamma/PKM2-mediated glycolysis. J Exp Clin Canc Res. 2020;39(1):24. doi:10.1186/s13046-020-1528-x
   PubMed Web of Science ®Google Scholar
• Garcia-Carceles J, Caballero E, Gil C, Martinez A. Kinase inhibitors as underexplored antiviral agents. J Med Chem. 2021. doi:10.1021/acs.jmedchem.1c00302
   PubMed Web of Science ®Google Scholar
• Chibon F. Cancer gene expression signatures - the rise and fall? Eur J Cancer. 2013;49(8):2000–2009. doi:10.1016/j.ejca.2013.02.021
   PubMed Web of Science ®Google Scholar
• Qian Y, Daza J, Itzel T, et al. Prognostic cancer gene expression signatures: current status and challenges. Cells. 2021;10(3):648. doi:10.3390/cells10030648
   PubMed Web of Science ®Google Scholar
• Liu C, Dai Q, Ding Q, Wei M, Kong X. Identification of key genes in hepatitis B associated hepatocellular carcinoma based on WGCNA. Infect Agents Cancer. 2021;16(1):18. doi:10.1186/s13027-021-00357-4
   PubMed Web of Science ®Google Scholar
• Liu W, Tu W, Li L, et al. Revisiting connectivity map from a gene co-expression network analysis. Exp Ther Med. 2018;16(2):493–500. doi:10.3892/etm.2018.6275
   PubMed Web of Science ®Google Scholar
• Liu W, Li L, Li W. Gene co-expression analysis identifies common modules related to prognosis and drug resistance in cancer cell lines. Int J Cancer. 2014;135(12):2795–2803. doi:10.1002/ijc.28935
   PubMed Web of Science ®Google Scholar
• Patil P, Bachant-Winner P-O, Haibe-Kains B, Leek JT. Test set bias affects reproducibility of gene signatures. Bioinformatics. 2015;31(14):2318–2323. doi:10.1093/bioinformatics/btv157
   PubMed Web of Science ®Google Scholar
• Denoyer D, Perek N, Le Jeune N, Cornillon J, Dubois F. Correlation between 99mTc-(V)-DMSA uptake and constitutive level of phosphorylated focal adhesion kinase in an in vitro model of cancer cell lines. Eur J Nucl Med Mol I. 2005;32(7):820–827. doi:10.1007/s00259-005-1773-4
   PubMed Web of Science ®Google Scholar
• Gibson K, Rindone JP. Experience with statin use in patients with chronic hepatitis C infection. Am J Cardiol. 2005;96(9):1278–1279. doi:10.1016/j.amjcard.2005.06.071
   PubMed Web of Science ®Google Scholar
• Zapatero-Belinchon FJ, Otjengerdes R, Sheldon J, et al. Interdependent impact of lipoprotein receptors and lipid-lowering drugs on HCV infectivity. Cells. 2021;10(7):1626. doi:10.3390/cells10071626
   PubMed Web of Science ®Google Scholar
• Li M, Wang Q, Lin W, Wang B. Regulation of ovarian cancer cell adhesion and invasion by chloride channels. Int J Gynecol Cancer. 2009;19(4):526–530. doi:10.1111/IGC.0b013e3181a3d6d2
   PubMed Web of Science ®Google Scholar
• Li XS, Ren YC, Bao YZ, et al. Synthesis of C3-Neoglycosides of digoxigenin and their anticancer activities. Eur J Med Chem. 2018;145:252–262. doi:10.1016/j.ejmech.2017.12.086
   PubMed Web of Science ®Google Scholar
• Kumari S, Badana AK, Mohan GM, Shailender Naik G, Malla R. Synergistic effects of coralyne and paclitaxel on cell migration and proliferation of breast cancer cells lines. Biomed Pharmacother. 2017;91:436–445. doi:10.1016/j.biopha.2017.04.027
   PubMed Web of Science ®Google Scholar